IOB - Delayed Quote USD
Johnson & Johnson (0R34.IL)
155.60
-2.30
(-1.46%)
At close: 7:13:51 PM GMT+1
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | -- | -- |
Sales | -- | -- |
Net Shares Purchased (Sold) | -- | -- |
Total Insider Shares Held | -- | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
DUATO JOAQUIN BOIX Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 18, 2025 |
DECKER ROBERT J Officer | Conversion of Exercise of derivative security at price 101.87 per share. | Direct | 712,988 | Feb 25, 2025 |
DECKER ROBERT J Officer | Sale at price 165.88 per share. | Direct | 1,160,994 | Feb 25, 2025 |
SCHMID TIMOTHY Officer | Sale at price 156.15 per share. | Direct | 62,928 | Feb 18, 2025 |
DECKER ROBERT J Officer | -- | Direct | -- | Feb 14, 2025 |
SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 14, 2025 |
SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 14, 2025 |
SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 14, 2025 |
MULHOLLAND KRISTEN Officer | -- | Direct | -- | Feb 14, 2025 |
BROADHURST VANESSA Officer | -- | Direct | -- | Feb 14, 2025 |
REED JOHN C Officer | -- | Direct | -- | Feb 14, 2025 |
WENGEL KATHRYN E Chief Technology Officer | -- | Direct | -- | Feb 14, 2025 |
DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 14, 2025 |
WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 14, 2025 |
TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 14, 2025 |
WENGEL KATHRYN E Chief Operating Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 3,278,166 | Feb 7, 2025 |
DUATO JOAQUIN BOIX Chief Executive Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 12,644,482 | Feb 7, 2025 |
WOLK JOSEPH J Chief Financial Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 1,302,281 | Feb 7, 2025 |
TAUBERT JENNIFER L Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 5,853,910 | Feb 7, 2025 |
WOLK JOSEPH J Chief Financial Officer | Sale at price 153.89 per share. | Direct | 2,002,878 | Feb 7, 2025 |
WEINBERGER MARK A Director | Purchase at price 147.22 per share. | Direct | 147,220 | Dec 12, 2024 |
WOLK JOSEPH J Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Oct 17, 2024 |
DECKER ROBERT J Officer | Conversion of Exercise of derivative security at price 100.06 per share. | Direct | 563,838 | Aug 30, 2024 |
DECKER ROBERT J Officer | Sale at price 165.06 per share. | Direct | 930,113 | Aug 30, 2024 |
BROADHURST VANESSA Officer | -- | Direct | -- | Jul 8, 2024 |
REED JOHN C Officer | -- | Direct | -- | May 1, 2024 |
REED JOHN C Officer | -- | Direct | -- | May 1, 2024 |
WOODS EUGENE A Director | Purchase at price 145.53 per share. | Indirect | 14,553 | Apr 30, 2024 |
BROADHURST VANESSA Officer | Sale at price 162.16 per share. | Direct | 1,441,765 | Mar 13, 2024 |
DECKER ROBERT J Officer | -- | Direct | -- | Feb 13, 2024 |
SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 13, 2024 |
FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 13, 2024 |
SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 13, 2024 |
HAIT WILLIAM Officer | -- | Direct | -- | Feb 13, 2024 |
BROADHURST VANESSA Officer | -- | Direct | -- | Feb 13, 2024 |
FASOLO PETER M Officer | -- | Direct | -- | Feb 13, 2024 |
WENGEL KATHRYN E Officer | -- | Direct | -- | Feb 13, 2024 |
DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 13, 2024 |
WOLK JOSEPH J Chief Financial Officer | -- | Direct | -- | Feb 13, 2024 |
TAUBERT JENNIFER L Officer | -- | Direct | -- | Feb 13, 2024 |
DECKER ROBERT J Officer | -- | Direct | -- | Feb 12, 2024 |
SWANSON JAMES D Chief Technology Officer | -- | Direct | -- | Feb 12, 2024 |
FORMINARD ELIZABETH General Counsel | -- | Direct | -- | Feb 12, 2024 |
SCHMID TIMOTHY Officer | -- | Direct | -- | Feb 12, 2024 |
HAIT WILLIAM Officer | -- | Direct | -- | Feb 12, 2024 |
BROADHURST VANESSA Officer | -- | Direct | -- | Feb 12, 2024 |
FASOLO PETER M Officer | -- | Direct | -- | Feb 12, 2024 |
WENGEL KATHRYN E Chief Technology Officer | -- | Direct | -- | Feb 12, 2024 |
DUATO JOAQUIN BOIX Chief Executive Officer | -- | Direct | -- | Feb 12, 2024 |
Related Tickers
D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
PFE.BE Pfizer Inc
19.71
-0.46%
AMGN.MX Amgen Inc.
5,500.00
0.00%
NOTA.DU Novartis AG
97.40
+0.41%
PFE.DU Pfizer Inc
19.98
+1.34%
4AB.F AbbVie Inc.
155.80
+0.65%
PFE.VI Pfizer Inc.
20.03
+0.18%
0Q1N.IL Pfizer Inc.
22.75
+1.22%
PFIZ34.SA Pfizer Inc.
32.17
+1.16%
OPHLY Ono Pharmaceutical Co., Ltd.
3.9000
-0.51%